Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-013256
Filing Date
2025-04-10
Accepted
2025-04-10 16:11:20
Documents
7
Period of Report
2025-05-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20044910x3_def14a.htm DEF 14A 380891
2 logo_plustherapeutics1.jpg GRAPHIC 33360
3 ny20044910x3_internet.jpg GRAPHIC 5735
4 ny20044910x3_mail.jpg GRAPHIC 6660
5 ny20044910x3_pc01.jpg GRAPHIC 958217
6 ny20044910x3_pc02.jpg GRAPHIC 685948
7 ny20044910x3_phone.jpg GRAPHIC 6434
  Complete submission text file 0001140361-25-013256.txt   2717221
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34375 | Film No.: 25828524
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)